Literature DB >> 10933449

Utility of multimodal evoked potential study and electroencephalography in mitochondrial encephalomyopathy.

V Scaioli1, C Antozzi, F Villani, M Rimoldi, M Zeviani, F Panzica, G Avanzini.   

Abstract

We performed electroencephalography (EEG) and multimodal evoked potential (EP) studies in 16 patients with various forms of mitochondrial encephalomyopathy (ME). The electrophysiological investigations revealed signs of involvement of the peripheral and central nervous system (CNS) in 14 patients, with a high incidence of visual-EP (VEP) alterations, indicative of visual pathway vulnerability in mitochondrial diseases. No specific pattern of abnormalities emerged and, in particular, clinical and laboratory findings did not correlate with each other. EP (particularly VEP and electroretinogram) investigations should be part of the diagnostic work-up of patients with mitochondrial disorders in order to better characterize the clinical picture, disclose involvement of specific sensory systems of the CNS, and assess patients with atypical clinical presentations.

Entities:  

Mesh:

Year:  1998        PMID: 10933449     DOI: 10.1007/bf00713855

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  28 in total

1.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

2.  Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation.

Authors:  J M Shoffner; M T Lott; A M Lezza; P Seibel; S W Ballinger; D C Wallace
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

3.  Alterations of oligodendrocytes and demyelination in the spinal cord of patients with mitochondrial encephalomyopathy.

Authors:  S Ohara; E Ohama; H Takahashi; F Ikuta; M Nishizawa; K Tanaka; T Miyatake
Journal:  J Neurol Sci       Date:  1988-08       Impact factor: 3.181

4.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome.

Authors:  S G Pavlakis; P C Phillips; S DiMauro; D C De Vivo; L P Rowland
Journal:  Ann Neurol       Date:  1984-10       Impact factor: 10.422

5.  Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

Authors:  G L Krauss; M A Johnson; N R Miller
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

6.  EEG and evoked potential findings in mitochondrial myopathies.

Authors:  S J Smith; A E Harding
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

7.  Clinical and EEG findings in eleven patients affected by mitochondrial encephalomyopathy with MERRF-MELAS overlap.

Authors:  G Serra; R Piccinnu; M Tondi; F Muntoni; M Zeviani; C Mastropaolo
Journal:  Brain Dev       Date:  1996 May-Jun       Impact factor: 1.961

8.  Deletions of mitochondrial DNA in Kearns-Sayre syndrome.

Authors:  M Zeviani; C T Moraes; S DiMauro; H Nakase; E Bonilla; E A Schon; L P Rowland
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

9.  Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease.

Authors:  M Zeviani; N Bresolin; C Gellera; A Bordoni; M Pannacci; P Amati; M Moggio; S Servidei; G Scarlato; S DiDonato
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

10.  Electrophysiological exploration of visual function in mitochondrial diseases.

Authors:  F Rigaudière; N Manderieux; J F Le Gargasson; J E Guez; Y Grall
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1995-11
View more
  2 in total

1.  Electrophysiological evaluation of visual pathways in paclitaxel-treated patients.

Authors:  V Scaioli; A Caraceni; C Martini; S Curzi; G Capri; G Luca
Journal:  J Neurooncol       Date:  2005-08-25       Impact factor: 4.130

2.  Visual pathways evaluation in Kearns Sayre syndrome: a diffusion tensor imaging study.

Authors:  Maria Camilla Rossi-Espagnet; Martina Lucignani; Luca Pasquini; Antonio Napolitano; Stefano Pro; Andrea Romano; Daria Diodato; Diego Martinelli; Daniela Longo
Journal:  Neuroradiology       Date:  2019-11-04       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.